2826-55-3 Usage
1-Cyclohexene-1-butanoic acid
A chemical compound consisting of 10 carbon atoms, 16 hydrogen atoms, and 2 oxygen atoms.
Carboxylic acid
A compound with a carboxyl group (-COOH) at the end of its molecule, which gives it acidic properties.
Cyclohexene ring
A six-carbon ring structure with alternating single and double bonds, providing the compound with a unique aromatic character.
Production of fragrances, perfumes, and flavorings
Due to its pleasant odor, 1-Cyclohexene-1-butanoic acid is used as a key ingredient in various personal care and food products.
Anti-inflammatory properties
The compound has the ability to reduce inflammation, making it a potential candidate for pharmaceutical applications.
Analgesic properties
1-Cyclohexene-1-butanoic acid exhibits pain-relieving properties, which can be beneficial in the treatment of various conditions.
Potential role in treating gastrointestinal disorders
The compound has been studied for its possible effects on the gastrointestinal system, which could lead to new treatment options for related disorders.
Anticonvulsant effects
1-Cyclohexene-1-butanoic acid has been researched for its potential to prevent or reduce the severity of seizures, indicating possible use in treating epilepsy and other seizure-related conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 2826-55-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,8,2 and 6 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 2826-55:
(6*2)+(5*8)+(4*2)+(3*6)+(2*5)+(1*5)=93
93 % 10 = 3
So 2826-55-3 is a valid CAS Registry Number.
2826-55-3Relevant academic research and scientific papers
Enantioselective bromolactonization of aryl functionalized alkenoic acids
Hansen, Trond Vidar,Kristianslund, Renate
, (2020/03/04)
Aryl substituted 1,1-disubstituted alkenoic carboxylic acids were subjected to an enantioselective organocatalyzed protocol, yielding the corresponding δ-bromolactones in a regioselective manner. The products were isolated in good to high yields with enantiomeric excess in the range of 18–88%.
